Ekso Bionics Holdings, Inc. (EKSO)
USD 0.38
(-2.3%)
USD 0.38
(-2.3%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.83 Million USD | -0.45% |
| 2022 | 4.85 Million USD | 143.55% |
| 2021 | 1.99 Million USD | -39.75% |
| 2020 | 3.3 Million USD | 195.89% |
| 2019 | 1.11 Million USD | -57.78% |
| 2018 | 2.64 Million USD | -45.18% |
| 2017 | 4.83 Million USD | -28.86% |
| 2016 | 6.78 Million USD | 32228.57% |
| 2015 | 21 Thousand USD | -72.73% |
| 2014 | 77 Thousand USD | -91.12% |
| 2013 | 867 Thousand USD | -65.45% |
| 2012 | 2.5 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 4.1 Million USD | -5.65% |
| 2024 Q2 | 4.35 Million USD | -5.27% |
| 2024 Q1 | 4.59 Million USD | -4.93% |
| 2023 Q2 | 4.2 Million USD | -7.17% |
| 2023 Q4 | 4.83 Million USD | -17.87% |
| 2023 FY | 4.83 Million USD | -0.45% |
| 2023 Q1 | 4.53 Million USD | -6.61% |
| 2023 Q3 | 5.88 Million USD | 39.81% |
| 2022 Q1 | 1.99 Million USD | 0.05% |
| 2022 Q4 | 4.85 Million USD | 315.94% |
| 2022 Q3 | 1.16 Million USD | -44.67% |
| 2022 FY | 4.85 Million USD | 143.55% |
| 2022 Q2 | 2.1 Million USD | 5.77% |
| 2021 Q4 | 1.99 Million USD | 0.05% |
| 2021 Q1 | 2.36 Million USD | -28.63% |
| 2021 FY | 1.99 Million USD | -39.75% |
| 2021 Q3 | 1.99 Million USD | 0.05% |
| 2021 Q2 | 1.99 Million USD | -15.67% |
| 2020 Q3 | 3.45 Million USD | 199.65% |
| 2020 Q2 | 1.15 Million USD | 93.61% |
| 2020 FY | 3.3 Million USD | 195.89% |
| 2020 Q4 | 3.3 Million USD | -4.17% |
| 2020 Q1 | 595 Thousand USD | -46.78% |
| 2019 Q4 | 1.11 Million USD | -37.54% |
| 2019 FY | 1.11 Million USD | -57.78% |
| 2019 Q3 | 1.79 Million USD | -27.5% |
| 2019 Q2 | 2.46 Million USD | -20.33% |
| 2019 Q1 | 3.09 Million USD | 17.03% |
| 2018 Q2 | 3.74 Million USD | -12.68% |
| 2018 Q1 | 4.29 Million USD | -11.18% |
| 2018 Q4 | 2.64 Million USD | -17.22% |
| 2018 FY | 2.64 Million USD | -45.18% |
| 2018 Q3 | 3.19 Million USD | -14.6% |
| 2017 Q4 | 4.83 Million USD | -10.02% |
| 2017 Q1 | 6.44 Million USD | -5.07% |
| 2017 Q3 | 5.36 Million USD | -9.11% |
| 2017 FY | 4.83 Million USD | -28.86% |
| 2017 Q2 | 5.9 Million USD | -8.36% |
| 2016 Q1 | 125 Thousand USD | 0.0% |
| 2016 Q2 | 108 Thousand USD | -13.6% |
| 2016 Q4 | 6.78 Million USD | 6757.58% |
| 2016 Q3 | 99 Thousand USD | -8.33% |
| 2016 FY | 6.78 Million USD | 32228.57% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q2 | 53 Thousand USD | -18.46% |
| 2015 Q1 | 65 Thousand USD | -15.58% |
| 2015 FY | 21 Thousand USD | -72.73% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q4 | 77 Thousand USD | -12.9% |
| 2014 Q2 | 99.95 Thousand USD | -10.21% |
| 2014 Q1 | 111.31 Thousand USD | -87.16% |
| 2014 FY | 77 Thousand USD | -91.12% |
| 2014 Q3 | 88.4 Thousand USD | -11.56% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | 867 Thousand USD | -30.48% |
| 2013 FY | 867 Thousand USD | -65.45% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q3 | 1.24 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | 2.5 Million USD | 0.0% |
| 2012 Q4 | 2.5 Million USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 93.579% |
| AngioDynamics, Inc. | 3.93 Million USD | -22.671% |
| AtriCure, Inc. | 60.59 Million USD | 92.025% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 92.005% |
| BioLife Solutions, Inc. | 18.31 Million USD | 73.611% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 99.809% |
| Daxor Corporation | 755.65 Thousand USD | -539.442% |
| Femasys Inc. | 4.25 Million USD | -13.476% |
| GlucoTrack, Inc. | 196 Thousand USD | -2365.306% |
| Harvard Bioscience, Inc. | 30.7 Million USD | 84.263% |
| Hologic, Inc. | 2.49 Billion USD | 99.806% |
| ICU Medical, Inc. | 1.57 Billion USD | 99.694% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 105.886% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -32.278% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | 70.934% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 99.446% |
| Microbot Medical Inc. | 40 Thousand USD | -11980.0% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -105126.481% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 99.413% |
| Nephros, Inc. | 1.39 Million USD | -247.626% |
| NovoCure Limited | 596.24 Million USD | 99.19% |
| NEXGEL, Inc. | 513 Thousand USD | -841.91% |
| NEXGEL, Inc. | 513 Thousand USD | -841.91% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 92.844% |
| OraSure Technologies, Inc. | 11.38 Million USD | 57.569% |
| Pro-Dex, Inc. | 7.53 Million USD | 35.881% |
| Pulse Biosciences, Inc. | 8.08 Million USD | 40.242% |
| Predictive Oncology Inc. | 2.18 Million USD | -120.742% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -149.333% |
| QuidelOrtho Corporation | 2.27 Billion USD | 99.788% |
| Repligen Corporation | 510.14 Million USD | 99.053% |
| Sanara MedTech Inc. | 9.11 Million USD | 46.978% |
| STAAR Surgical Company | 31.46 Million USD | 84.644% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -1537.966% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.731% |
| Jin Medical International Ltd. | - USD | -Infinity% |